Articles dans des revues avec comité de lecture (210)
  1. 132. Bali, M. A., Metens, T., Denolin, V., Delhaye, M., Demetter, P., Closset, J., & Ma, S. (2011). Tumoral and Nontumoral Pancreas: Correlation between Quantitative Dynamic Contrast-enhanced MR Imaging and Histopathologic Parameters. Radiology, 26, 456-466. doi:10.1148/radiol.11103515
  2. 133. Van Laethem, J.-L., Verslype, C., Iovanna, J., Michl, P., Conroy, T., Louvet, C., Hammel, P., Mitry, E., Ducreux, M., Maraculla, T., Uhl, W., Van Tienhoven, G., Bachet, J. B., Marechal, R., Hendlisz, A., Bali, M. A., Demetter, P., Ulrich, F., Aust, D., Luttges, J., Peeters, M., Mauer, M., Roth, A., Neoptolemos, J., & Lutz, M. B. (2011). New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel. Annals of oncology, 23(3), 570-576. doi:10.1093/annonc/mdr351
  3. 134. Toussaint, E., Flamen, P., Demetter, P., Matos Pinto De Almeida, C., Van Gossum, M., Delhaye, M., Closset, J., Loi, P., Devière, J., & Arvanitakis, M. (2011). A rare case of a pancreatic mass due to accessory spleen; when EUS-FNA is not enough. Endoscopy, 43 Suppl 2 UCTN, E221-E222. doi:10.1055/s-0030-1256421
  4. 135. Casneuf, V. F., Delrue, L., Van Damme, N., Demetter, P., Robert, P., Corot, C., Duyck, P., Ceelen, W., Boterberg, T., & Peeters, M. (2011). Noninvasive monitoring of therapy-induced microvascular changes in a pancreatic cancer model using dynamic contrast-enhanced magnetic resonance imaging with P846, a new low-diffusible gadolinium-based contrast agent. Radiation research, 175(1), 10-20. doi:10.1667/RR2068.1
  5. 136. Jouret-Mourin, A., Hoorens, A., Kockx, M., Demetter, P., & Van Cutsem, E. (2011). Belgian guidelines for HER2 testing in gastric cancer. Belgian journal of medical oncology, 5, 14-22.
  6. 137. Deconinck, J., Demetter, P., Geurs, F., & Deloecker, R. (2011). Urachal carcinoma with liver, lung, and brain metastases: benefit of a new combination chemotherapy (bevacizumab, 5-fluorouracil, irinotecan) – case report. Clinical oncology in adolescents and young adults, 1(11), 15.
  7. 138. Marechal, R., Demetter, P., & Van Laethem, J.-L. (2011). Prognostic and predictive markers in pancreatic adenocarcinoma. Belgian journal of medical oncology, 5, 77-79.
  8. 139. Marechal, R., Mackey, J. R., Lai, R., Demetter, P., Peeters, M., Polus, M., Cass, C. E., Salmon, I., Devière, J., & Van Laethem, J.-L. (2010). Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma. Cancer, 116(22), 5200-5206. doi:10.1002/cncr.25303
  9. 140. Taildeman, J., Demetter, P., Rottiers, I., Holtappels, G., Bachert, C., Cuvelier, C., & Pérez-Novo, C. A. (2010). Identification of the nasal mucosa as a new target for leptin action. Histopathology, 56(6), 789-798. doi:10.1111/j.1365-2559.2010.03552.x
  10. 141. Hoorens, A., Jouret-Mourin, A., Sempoux, C., Demetter, P., De Hertogh, G., & Teugels, E. (2010). Accurate KRAS mutation testing for EGFR-targeted therapy in colorectal cancer: emphasis on the key role and responsibility of pathologists. Acta gastro-enterologica Belgica (Ed. multilingue), 73(4), 497-503.
  11. 142. Vandenbroucke, K., de Haard, H., Beirnaert, E., Dreier, T., Lauwereys, M., Huyck, L., Van Huysse, J., Demetter, P., Steidler, L., Remaut, E., Cuvelier, C. A., & Rottiers, P. (2010). Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis. Mucosal Immunology, 3(1), 49-56. doi:10.1038/mi.2009.116
  12. 143. Marechal, R., De Schutter, J., Nagy, N., Demetter, P., Lemmers, A., Devière, J., Salmon, I., Tejpar, S., & Van Laethem, J.-L. (2010). Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients. BMC cancer, 10, 340. doi:10.1186/1471-2407-10-340
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Suivant >>